Search
for

    Sort by

    Research 91–120 of 1000+

    1. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    2. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    3. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    4. The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH Journal of Jilin Medical College · 2009
    5. Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men Cancer Epidemiology and Prevention Biomarkers · 2007
    6. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    7. Effect of Low-Dose Finasteride on Serum PSA Concentrations Journal watch · 2007
    8. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    9. Editorial comment 1 Urology · 2004
    10. Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo European Urology Supplements · 2003
    11. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    12. Bernstein’s Consent and Information on Finasteride and Propecia® Hair transplant forum international · 2016
    13. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    14. Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    15. 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 생약학회지 · 2007
    16. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    17. Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice PLOS ONE · 2013 · 9 citations
    18. UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia? Urology · 2011
    19. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    20. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    21. One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital Indian journal of health sciences and biomedical research KLEU · 2017
    22. Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial The World Journal of Men s Health · 2023 · 5 citations
    23. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    24. 1465 骨材がコンクリートの乾燥収縮ひずみに及ぼす影響 : その1. 実験計画および実験結果(収縮・クリープ(5),材料施工) 学術講演梗概集. A-1, 材料施工 · 2010
    25. Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses Nature Clinical Practice Urology · 2007
    26. A Review on the Clinical Utility of PSA in Cancer Prostate Indian Journal of Surgical Oncology · 2012 · 154 citations
    27. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    28. How not to detect prostate cancer Lancet Oncology · 2007
    29. FINASTERIDE AND PSA The Journal of Urology · 2005
    30. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations